tiprankstipranks
Trending News
More News >
China Risun Group Ltd. (HK:1907)
:1907
Advertisement

China Risun Group Ltd. (1907) AI Stock Analysis

Compare
0 Followers

Top Page

HK:1907

China Risun Group Ltd.

(Frankfurt:1907)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 4o)
Rating:54Neutral
Price Target:
HK$2.50
▲(5.49% Upside)
The overall stock score of 54 reflects the company's stable revenue growth but significant profitability challenges and high leverage. The technical analysis indicates a bearish trend, while the valuation is impacted by a negative P/E ratio. The dividend yield provides some support, but overall, the stock faces multiple headwinds.

China Risun Group Ltd. (1907) vs. iShares MSCI Hong Kong ETF (EWH)

China Risun Group Ltd. Business Overview & Revenue Model

Company DescriptionChina Risun Group Ltd. (1907) is a leading enterprise in the manufacturing and distribution of coal-related products and chemicals, primarily operating in the fields of coking, chemical production, and logistics. The company serves a diverse range of industries, including steel, energy, and construction, with a focus on producing high-quality metallurgical coke, coal tar, and other chemical products. With its strong operational capabilities and extensive supply chain network, Risun Group is positioned as a key player in the coal and chemical industries in China.
How the Company Makes MoneyChina Risun Group Ltd. generates revenue primarily through the production and sale of metallurgical coke and chemical products derived from coal. Key revenue streams include sales of coke to steel manufacturers, which constitutes a significant portion of its income, as well as the sale of by-products such as coal tar and ammonia. The company also engages in logistics services, facilitating the transportation and distribution of its products. Strategic partnerships with major steel companies and chemical manufacturers enhance its market position and contribute to stable income streams. Additionally, factors such as favorable government policies in the coal and chemical sectors and investments in technology and production efficiency play a crucial role in bolstering its earnings.

China Risun Group Ltd. Financial Statement Overview

Summary
China Risun Group Ltd. demonstrates stable revenue growth but faces profitability challenges with a declining net profit margin. The balance sheet reveals high leverage, posing financial risks, though the equity ratio indicates a balanced asset structure. Cash flow generation shows improvement, reflecting operational resilience, but net income volatility remains a concern.
Income Statement
60
Neutral
The company shows a stable revenue growth trend with a Revenue Growth Rate of 3.20% in 2024 compared to 2023. However, the net profit margin has significantly decreased to 0.04% in 2024, indicating profitability challenges. Gross Profit Margin is moderate at 7.34%, and the EBIT Margin has decreased to 2.97% in 2024, suggesting reduced operational efficiency.
Balance Sheet
55
Neutral
The Debt-to-Equity Ratio is relatively high at 2.38, indicating significant leverage, which poses a risk. Return on Equity (ROE) has drastically fallen to 0.16% in 2024, suggesting poor profitability relative to shareholder equity. The Equity Ratio remains moderate at 21.32%, indicating a balanced asset structure but high reliance on debt.
Cash Flow
65
Positive
The Free Cash Flow Growth Rate shows a strong increase, reflecting improved cash generation. However, Operating Cash Flow to Net Income Ratio has weakened due to the drop in net income. The Free Cash Flow to Net Income Ratio is favorable, indicating resilience in cash flow generation despite profitability issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue42.88B47.54B46.07B43.14B39.37B19.78B
Gross Profit3.32B3.49B3.32B4.28B5.53B3.22B
EBITDA3.40B3.50B4.37B4.63B5.45B3.22B
Net Income-63.08M20.13M860.81M1.86B2.61B1.65B
Balance Sheet
Total Assets63.26B59.84B53.84B46.10B36.80B24.21B
Cash, Cash Equivalents and Short-Term Investments2.76B2.26B1.25B1.40B2.37B1.19B
Total Debt35.13B30.38B26.31B20.70B13.80B10.57B
Total Liabilities47.62B43.96B39.36B33.51B25.69B15.94B
Stockholders Equity12.57B12.76B12.90B12.11B10.98B8.13B
Cash Flow
Free Cash Flow2.46B-1.24B134.87M-1.22B534.69M-725.01M
Operating Cash Flow2.42B1.44B2.20B3.16B4.21B1.14B
Investing Cash Flow-7.05B-3.64B-1.71B-9.18B-5.13B-2.19B
Financing Cash Flow3.32B3.05B-455.15M4.93B2.02B1.16B

China Risun Group Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.37
Price Trends
50DMA
2.40
Negative
100DMA
2.44
Negative
200DMA
2.51
Negative
Market Momentum
MACD
-0.02
Positive
RSI
47.07
Neutral
STOCH
18.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1907, the sentiment is Negative. The current price of 2.37 is above the 20-day moving average (MA) of 2.37, below the 50-day MA of 2.40, and below the 200-day MA of 2.51, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 47.07 is Neutral, neither overbought nor oversold. The STOCH value of 18.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1907.

China Risun Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
HK$4.08B7.189.36%6.97%-3.73%6.09%
62
Neutral
HK$16.23B11.7410.43%0.93%-1.43%113.67%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
HK$1.21B16.883.61%1.85%-8.51%-68.34%
57
Neutral
HK$2.78B3.6913.87%9.20%213.87%
54
Neutral
HK$10.29B-145.28-0.52%1.13%-15.17%-125.24%
54
Neutral
HK$1.22B18.942.46%3.73%-5.29%-32.47%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1907
China Risun Group Ltd.
2.35
-0.90
-27.58%
HK:0609
Tiande Chemical Holdings Limited
1.34
0.24
21.82%
HK:1702
Dongguang Chemical Ltd.
1.95
-0.11
-5.34%
HK:0189
Dongyue Group Limited
10.71
4.04
60.57%
HK:2198
China Sanjiang Fine Chemicals Co., Ltd.
2.46
0.61
32.97%
HK:0746
Lee & Man Chemical Co. Ltd.
4.95
1.33
36.74%

China Risun Group Ltd. Corporate Events

China Risun Group Sells Subsidiary Stake in Strategic Move
Oct 31, 2025

China Risun Group Ltd. announced the disposal of its 100% equity interest in a subsidiary to Xuyang New Energy for RMB54,686,200. This transaction, classified as a connected transaction due to the involvement of the company’s controlling shareholder, does not require independent shareholders’ approval. The sale aligns with the company’s strategic adjustments, impacting its financial consolidation and potentially altering its market positioning.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Terminates Framework Agreement with Beijing SinoHytec
Sep 5, 2025

China Risun Group Limited has announced the termination of a framework agreement with Beijing SinoHytec regarding a potential disposal and capital increase. The decision was made due to the inability to reach a consensus on the definitive plan, but the company assures that this will not adversely affect its business operations or financial position. The group remains open to future strategic cooperation with Beijing SinoHytec.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Adjusts Interim Dividend Record Date
Sep 1, 2025

China Risun Group Limited has announced a change in the book closure period and record date for its interim dividend for the six months ended June 30, 2025. The new book closure period is from September 16 to September 18, 2025, with the record date now set for September 18, 2025. This adjustment allows shareholders to ensure their eligibility for the RMB0.20 per share dividend, with the payment date remaining unchanged at September 30, 2025.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Updates Interim Dividend Schedule
Sep 1, 2025

China Risun Group Ltd. announced a change in the book closure period and record date for its interim cash dividend for the financial year ending December 31, 2025. The dividend declared is RMB 0.002 per share, with the ex-dividend date set for September 12, 2025, and payment scheduled for September 30, 2025. This update may affect shareholders’ planning and the company’s financial operations, reflecting its commitment to providing returns to investors.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Grants Share Awards to Key Personnel
Sep 1, 2025

China Risun Group Limited announced the grant of 9,915,000 share awards to 197 eligible participants, including directors and employees, under its Share Award Plan. The awarded shares, which are subject to performance targets and a vesting period of 60 months, aim to incentivize and retain key personnel. The grant reflects the company’s strategic focus on achieving revenue growth and operational efficiency, with a clawback mechanism in place to address any misconduct or financial misstatements.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Sees Production Growth Amid Financial Decline in Interim Results
Aug 29, 2025

China Risun Group Limited reported its unaudited interim results for the six months ended June 30, 2025, showing mixed performance. While the production volumes of coke, refined chemicals, and high-purified hydrogen increased significantly, the company experienced a decline in revenue and profits by 18.5% and 34.9% respectively, year-on-year. Basic earnings per share also saw a substantial decrease of 74.0%. The board declared an interim dividend of RMB0.20 cents per share, a reduction from the previous period. These results indicate operational growth but financial challenges, impacting stakeholders and market positioning.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Declares Interim Dividend Amidst 2025 Interim Results
Aug 29, 2025

China Risun Group Ltd. announced its unaudited interim results for the six months ending June 30, 2025, declaring an interim cash dividend of RMB 0.002 per share. This announcement reflects the company’s ongoing financial strategies and its commitment to providing returns to its shareholders, potentially impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (HK:1907) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on China Risun Group Ltd. stock, see the HK:1907 Stock Forecast page.

China Risun Group Schedules Board Meeting to Review Interim Results
Aug 19, 2025

China Risun Group Limited has announced that its Board of Directors will convene on August 29, 2025, to review and approve the interim financial results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, which could impact the company’s financial strategies and shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025